Concepedia

Karen N. Price

KN

Statistics

Publications

96

Citations

16.1K

H-Index

58

Active since

1988

Affiliations

International Breast Cancer Study Group(Current)

European Institute of Oncology

Dana-Farber Cancer Institute

Frontier Science & Technology Research Foundation, Inc.

The University of Sydney

Karen N. Price is an author at International Breast Cancer Study Group specializing in medicine, oncology, and breast oncology.

Publications per year

1988–2020

96

Publications

96

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

Viviana Galimberti, Bernard F. Cole, Stefano Zurrida et al. · The Lancet Oncology · 2013 · 1.2K citations · Full text

Medicine, Oncology, Surgery +13

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

Alan S. Coates, Aparna Keshaviah, Beat Thürlimann et al. · Journal of Clinical Oncology · 2007 · 904 citations

Medicine, Oncology, Breast Oncology +13

Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.

B.A. Gusterson, RD Gelber, Aron Goldhirsch et al. · Journal of Clinical Oncology · 1992 · 843 citations

Medicine, Oncology, Breast Oncology +13

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

Olivia Pagani, Meredith M. Regan, Barbara Walley et al. · New England Journal of Medicine · 2014 · 747 citations · Full text

Medicine, Gynecology, Oncology +17

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

Prudence A. Francis, Meredith M. Regan, Gini F. Fleming et al. · New England Journal of Medicine · 2014 · 727 citations · Full text

Medicine, Gynecology, Oncology +16

1–5 of 96